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Summary 
Mice that lack a functional ~/c subunit of the receptors for interleukin  (IL)-2, IL-4, IL-7, IL-9, 
and IL-15 display profound defects in lymphoid development.  The IL-7/IL-7R system repre- 
sents a critical interaction for conventional T  and B cell development. In this report, the role of 
IL-7Re~ in the development of lymphoid lineages other than conventional T  and B  cells was 
examined.  We demonstrate that ~/8 + T  cells  were absent in IL-7Rc~-deficient mice, whereas 
the development and function of natural killer cells were normal. Thus, IL-7RoL function is re- 
quired for the development of'v8  + T  cells but not natural killer cells. 
L 
Ymphocyte development is critically dependent on cy- 
tokines for the  expansion and differentiation  of multi- 
potential  progenitors.  Mutations  in  the  ~/c subunit  of the 
receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 (1-8) in hu- 
mans  result  in  X-linked  severe  combined  immunodefi- 
ciency (SCID)  (9).  This disease is characterized by the ab- 
sence  or greatly reduced numbers of T  cells and NK cells 
with the presence of nonfunctional B  cells (10). Mice lack- 
ing ~/c  exhibit  defects  in lymphoid development  that  ap- 
pear more severe than human X-linked SCID. These mice 
are  deficient  in  the  development  of T  cells,  B  cells,  NK 
cells,  Thy-1 + "V8 dendritic  epidermal T  cells  (DETC),  and 
intraepithelial  lymphocytes  (IEL)  (11,  12).  Because  ~/c  is 
shared  by at  least  five  cytokine  receptors,  this  phenotype 
likely results from the disruption  of the function of several 
cytokines.  Recently,  IL-7 has  been  identified  as  one  key 
cytokine  for  lymphocyte  development.  For  mice  treated 
with mAbs to IL-7 or IL-7Rc~ (13-15),  or deficient in ex- 
pression of the IL-7 or the IL-7Ra genes (16, 17), T  and B 
cell development was blocked at very early stages. It is not 
known,  however,  whether  signaling  through  IL-7RoL is 
also critical for supporting the  development of other lym- 
phoid lineages,  such  as  NK and ~/8 +  DETC  cells.  In this 
study,  this  issue  was  examined  by phenotypic  and  func- 
tional  analysis  of IL-7K~x-deficient  mice.  We  show  here 
that  "y8  +  T  cells  are  absent,  while  the  development  and 
function of NK cells are normal in IL-7R~x-deficient mice. 
Materials and Methods 
Animals.  IL-7Re~ deficient mice, back-crossed for five gener- 
ations to C57BL/6 mice, were kindly provided by Immunex Ke- 
search  and  Development  Corp.  (Seattle,  WA)  (17).  C57BL/6 
mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME) or obtained from the Specialized Animal Facility at the Uni- 
versity of Miami. 5-7-wk-old age-matched C57BL/6 mice were 
used as controls throughout the study. 
Flow Cytometric Analysis.  Cells from the thymus, spleen,  and 
skin  were  subjected  to  multicolor  staining  and  analyzed on  a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA) flow 
cytometer using LYSIS II software.  Before staining, cells were in- 
cubated with an mAb to the FcR (2.4G2)  to prevent nonspecific 
binding, and then sequentially  stained with biotinylated antibod- 
ies, PE-avidin, FITC-mAbs, and Cy-Chrome-mAbs. Data were 
collected from 104 viable  cells, as determined either by a combi- 
nation of forward and side scatter  or by staining  with propidium 
iodide.  The following mAbs were purchased from PharMingen 
(San Diego,  CA): biotin-GL3  (anti-'/8 TCR),  biotin-H57-597 
(anti-cx[3 TCR), biotin-PK136 (anti-NKl.1),  Cy-Chrome-RM- 
4-5 (anti-CD4), and Cy-Chrome-53-6.7 (anti-CDS~x). The fol- 
lowing antibodies  were purified  and labeled  in  our laboratory: 
FITC-145-2C11(anti-CD3~)  and  FITC-HO13.4  (anti-Thyl.2). 
The anti-IL-2R.~ mAb 5H4 was produced in our laboratory and 
described  elsewhere  (18). 
NKAssay.  To  assay spontaneous  NK  activity,  splenocytes 
were incubated with SlCr-labeled YAC-1 target cells (104) in 0.2 ml 
of RPMI  1640  medium  containing 5%  FCS  in  round-bottom 
plates  for 6  h,  and an aliquot  (0.1 ml)  of the  culture fluid  was 
counted in a gamma scintillation  counter as described  (19). IL-2- 
activated  NK (LAK) activity was examined by culturing spleno- 
cytes (2 ￿  106/ml) with 500 U/ml mouse rlL-2 for 72 h at 37~ 
in a humidified atmosphere containing 7% CO2 and then harvest- 
ing the  adherent  cells as effectors.  To test  the enhancement  of 
NK activity by Poly(I):(C) (Sigma Immunochemicals, St. Louis, 
MO), mice were injected intraperitoneally  with 100 p~g Poly(I):(C) 
48 and 72 h before harvesting  the spleen cells. Data are calculated 
as previously described  (19) and reported as the means of tripli- 
cate determinations with SD that varied by < 10%. 
Epidermal Cell Preparation.  Epidermal  cells were prepared by 
using the method described  by Sullivan et al. (20). Shaved mouse 
torso skins were removed and trimmed of subcutaneous fat and 
blood vessels. Each pelt was cut into 0.5-cm strips and placed der- 
mal side up in 0.3% trypsin (Boehringer Mannheim, Indianapolis, 
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fully scraped from the dermis and placed in fresh 0.3%  trypsin 
PBS containing 20 I~g/ml of DNAase [  (Sigma) at 37~  for 10 
min,  followed by addition of FCS  to  inactivate  trypsin.  Cells 
were further disaggregated mechanically by drawing and express- 
ing the cell suspension with a  5-nd syringe. Disaggregated cells 
were  then  centrifuged  over  Ficoll-Paque  (Pharmacia  Biotech, 
Uppsala, Sweden) at 25~  for 20 min. The cell band at the me- 
dium-Ficoll interface was harvested and washed three times with 
R.PMI 1640 medium before FACS  |  analysis. 
Results 
The Development and Funaion of NK Cells in IL- 7Ra'-defi- 
cient Mice.  To  examine whether  NK cell development is 
normal  in  the  lL-7K~x-mutant  mice,  splenocytes  were 
stained with mAbs to  NKI.1  and  CD3.  NK-I.1 +  CD3- 
cells were  easily detected  in  the  IL-7R~x-deficient mice 
(Fig. 1). Although the percentage ofNK-l.1 +  CD3-  cells 
in  the  spleen  from  IL-7R.o~-deficient  mice  is  -,~10-fold 
higher than that in spleen cells from age-matched C57BL/6 
mice, the actual numbers of these cells are similar for both 
normal and mutant mice (IL-71Le~  +/+:  3.3  +  0.3  ￿  106, 
n  =  6; IL-7R.c~ -/-:  3.5  +  0.2  ￿  106,  r, =  6). Since NK 
cells express relatively high levels of the IL-21:Z[3 chain (21), 
splenocytes were  further  analyzed with  the  5H4  mAb to 
the  IL-2R[3  chain.  As  expected,  almost all the  NK-I.1 + 
cells reacted with the anti-IL-2R[3 mAb (Fig. 1). These re- 
suits indicate that NK cell development is not obviously af- 
fected by the inactivation of the IL-7R.ol gene. 
To determine whether NK cells in the IL-7R.ct mutant 
mice  are  functional,  unfractionated splenocytes from  un- 
treated  or  Poly(I):(C)-treated mice  were  tested  for  their 
lytic  activity  on  the  NK-semitive  target,  YAC-t  cells. 
Poly(I):(C)  has  been  shown  to  induce  IFN  production 
from  macrophages,  which  in  turn  enhance  NK  activity 
(22).  Splenocytes from IL-7K~t-deficient mice readily lysed 
YAC-1  targets at levels that were higher than detected for 
normal C57BL/6 mouse spleen cells. (Fig. 2 A). The stron- 
ger lytic activity by IL-7Rcx-deficient splenocytes is most 
likely caused by a higher number  of NK-I.1 +  cells added 
in  the  assay.  The  lysis of YAC-t  targets  by  splenocytes 
from  Poly(I):(C)-treated  IL-7Ket-deficient  and  normal 
mice was greatly increased, reaching a maxhml level at E/T 
of 100:1 for cells from the IL-71Let-mutant mice (Fig. 2 A). 
These  findings  indicate  that  the  basal  and  Poly(I):(C)- 
induced NK activities are not affected by the inactivation of 
IL-7Kot gene. 
High concentration oflL-2 induces NK cells to differen- 
tiate into LAK cells (23).  To  determine whether NK cells 
differentiate into  LAK cells from  the  spleens of IL-7R.oL- 
mutant  mice,  splenocytes  from  normal  and  IL-7Rcx- 
mutant  mice  were  cultured with  a  high  concentration  of 
IL-2 for 72 h,  and the IL-2-activated NK activity was as- 
sessed for the adherent ceils. The IL-2-activated cells from 
the  IL-7Rcx-mutant mice  efficiendy lysed YAC-1  targets 
(Fig. 2  B). Thus, IL-7R0~ is not required for IL-2-induced 
NK activation. Collectively, these results demonstrate that 
the development and function of NK cells are not depen- 
dent on IL-7ILc~. 
7~,  +  T Cells Are Ab~t in IL- 7R~-deficient Mite.  Thy-1 + 
DETC  in the skin consist of a large population of cells that 
almost  exclusively  express  ~/8  TCK  (24).  To  examine 
whether ~/8 + DETC  were present in the skin of IL-7Rxx- 
mutant  mice,  epidermal cells were  prepared  and  directly 
stained with mAbs specific for T  cells. Epidermal cells from 
the Ficoll interface from control C57BL/6 mice contained 
readily detectable ~/8 + DETC  that varied from 2 to 10% in 
different  experiments.  Similar percentages  of CD3 +  and 
IL-7R,x +/+  IL-7Ra -/- 
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Figure 1.  The presence of NK cells in the spleens of IL-7t~ot mutant 
mice. Splenocytes from 6-wk-old control C57BL/6 (IL-7Ra +/+) and 
IL-7P,~x--deficient  rmce (IL-7Rot -/-)  were  stained with bloun-NK- 
1.1,  followed by  PE-streptavidin and  either  FITC-anti-CD3  (A)  or 
FITC-ann-IL-2R[3c  (B), and were analyzed by flow cytometry. Boxed 
areas are the popnlatiom referred to in the text. 
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NK acnwty from IL-7lLo~-defir  mice. (A) NK activity of 
fresh spienocytes from  untreated  and  Poly{l):(C)-treated 5-6-wk-old 
control C57BL/6 (+/+) and IL-7Ka-deficient  mice (-/--). (B) NK ac- 
uvity of the adherent fraction of spleen cells from 5-6-wk-old control 
C57BL/6 (+/+) and IL-7P,  xx-deficient  mice (-/-)  cultured with mlL-2 
(500 U/m0 for 72 h. Data represem the mean value of triplicates from 
one of  three sxmihr experiments. 
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Figure 3.  Absence  of~ + DETC in the skin oflL-7R.~-mutant  mice. 
Flow cytometric  analyses were performed on epidermal cells from 6-wk--old 
control C57BL/6  (IL-7R~ +/+)  and lL-7RQ-defident  rmce (IL-7Ro~ 
-/-). Interface epidermal cells were preincubated with an mAb to FcR, 
followed by  staining with either biotln--anti-TCIk'y~,  PE~streptavidin, 
FITC-anti-CD3, or FITC-anti-Thy1.2.  Percentages of positive cells are 
indicated. 
Thy1.2 + cells were also detected in the control skin. A rep- 
resentative  FACS  |  profile is shown in  Fig. 3.  By contrast, 
~/8+ DETC  were not detected  in  the skin from IL-71~0t- 
mutant mice (Fig. 3). These epidermal cells also lacked cells 
that express CD3  and Thyl.2  (Fig.  3).  These  results  were 
further  confirmed  by  direct  examination  of  epidermal 
sheets under fluorescence microscopy (data not shown). 
TCR. ~/B + cells  account for a very minor subset of cells 
in  thymus and  spleen  (25,  26).  To  detect ~/8+  T  cells in 
the  thymus,  cells  were  analyzed  by  three-color  staining. 
CD4-CD8-  thymocytes were gated and examined for ex- 
pression  of ~8  or a13  TCR.  The  "double-negative"  thy- 
mocytes from control mice contained 20--25% CD3 + cells, 
of which 30-40~  expressed ~8 TCI~ and 60-70~  expressed 
al3  TCtL  (Fig.  4  A).  By  contrast,  very few  CD4  CD8- 
TCR  ~8 + thymocytes were detected in the IL-7tLot--defi- 
cient mice,  while  a  correspondingly higher percentage  of 
CD4-CD8-  TCR. ett3 + thymocytes were found (Fig. 4 A). 
Since  the  majority  of CD4 §  or  CD8 +  T  cells  in  the 
spleen  express  (x13 TCtL  (26),  CD3+CD4-CD8 -  spleno- 
cytes  were  gated  and  analyzed  for  the  expression  of ~/B 
TCtL.  This  subset accounted for "~0.7% and 0.1% of un- 
fractionated  splenocytes  from  the  control  and  IL-7R0t- 
deficient  mice,  respectively.  Within  this  population,  36% 
of the  control cells  expressed ~/8 TCtL,  and an equal per- 
centage of the  cells  expressed cq3  TCI:L (Fig.  4  B).  In the 
IL-7ILc~-mutant mice,  very few  CD3+CD4-CD8 -  sple- 
nocytes  expressed  ",/8 TCR,  whereas  a  majority  of these 
cells expressed a[3 TCR  (Fig. 4 B). 
Discussion 
Three  important  points  emerge  from  this  study.  First, 
the  absence  of ~B +  T  cells  and  normal  development  and 
function  of NK  cells  in  IL-7P~a--deficient  mice  indicate 
that  inactivation  of IL-7 function  in  ~/c-mutant  mice  ac- 
counts for part,  but not all,  of the  defects in the  develop- 
ment  of multiple  lymphoid lineages.  Second,  both  IL.-7- 
and thymic stromal cell-derived lymphopoeifin (TSLP) (17) 
are not critically involved in the development and function 
of  NK  cells.  Third,  signaling  through  IL-7RQ  appears 
more critical for the development of ~/8 T  cells than for oq3 
T  cells. 
As IL-7 and IL-71Let-mutant mice exhibit severe defects 
in conventional T  and B  cell development,  it is clear that 
signaling through the  IL-7R0t is critical for both T  and B 
cell  development,  and  that  the  phenotype  of "yc-mutant 
mice  and  human  X-linked  SCID  is  as  least  partially  ex- 
plained by a deficiency in the IL-7/IL-7tL system. Further- 
more,  IL-7Rcx  is  a  subunit  for  not  only  IL-7,  but  also 
TSLP, which shares  many biological properties  with  IL-7 
(17,  27).  It  is  likely  that  the  more  severe  phenotype  in 
IL-7Ret-mutant  mice reflects  the  consequences  of inacti- 
vation  of both  IL-7  and  TSLP  function.  However,  the 
presence  of a  normal  number  of functional  NK  cells  in 
IL-7R(x-deficient  mice  demonstrates  that  the  IL-71L sys- 
tem  does  not solely explain  the  phenotype  of ~c-mutant 
mice and  indicate  that  the  development  of NK is depen- 
dent on a cytokine whose receptor uses ~c, but is indepen- 
dent of IL-7 and  IL-7R~x.  Since  the  development  of NK 
cells is normal in IL-2- and IL-4--deficient mice (28, 29), it 
is highly likely that these cytokines do not critically control 
NK development. 
Given the tremendous heterogeneity of'y~  + T  cells with 
respect  to  their  generation,  anatomical  localization,  and 
V  gene  segment  usages  (for review see  reference  24),  we 
were  surprised  that  no ~/B +  T  cells  were  detected  in  the 
skin, thymi, and spleens of IL-7Rax-mutant mice. Further- 
more, in studies that have investigated the role of'yc in IEL 
development, ~/~+ IELs were not detected in the small in- 
testines  of IL-71~ot-deficient mice  (He,  Y.-W.,  and  T.R. 
IL-TRa  +1+ 
IL-7Rct 4- 
A  CO4-8"  thymocytu  B  CD3+CO4" CDS"  splenocyt~ 
TCR?8  TCR(xI~  TCR76  TCRal3 
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Figure 4.  Absence of'yB+ T cells in the spleens and 
thynu of IL-71k0t mutant mice. (A) Thymocytes were 
stained with either biotin-anti-TCR'y8 or biotin-anti- 
TCILa[3,  followed by  PE-streptavidin, FITC-anti- 
CD4, and Cy-Chrome--anti-CD8; CD4-CD8- "dou- 
ble-negative" cells were gated and analyzed  for a[3 and 
￿9  y8 TCR. expression by collecting 5 ￿  103 viable cells. 
(B) Splenocytes were stained with either biotin-anti- 
TCR'yB  or  biotin-anti-TCIket[3, followed by  PE- 
streptavidin, FITC-anti-CD3,  Cy-Chrome-anti-CD4, 
and  Cy-Chrome-anti-CD8;  the  CI)3+CD4-CD8  - 
cells were gated and analyzed for et[3 and 2r  TCIL ex- 
pression by collecting 5 ￿  103 viable cells. Percentages 
of positive cells are indicated in both panels. Malek,  unpublished data).  Thus,  IL-7Rot signaling appears 
to be required for the development of all y8 + T  cells.  Our 
findings are consistent with several in vitro studies that dem- 
onstrated a role for IL-7 in inducing expression of~/8 TCR 
by CD3-CD4-CD8-  thymocytes  (30)  and  in  supporting 
the  growth  of DETC  (31).  However,  the  precise  role  of 
IL-7Rot for ~/8 T  cell development is unknown.  Signaling 
via this receptor may be critical for commitment to the y8 
T  cell lineage, or after commitment, it may be essential for 
y8 TCR rearrangement. 
There  is  an  obvious dichotomy in  the  requirement  for 
IL-7Re~ function for development of y8 + and ot13  + T  cells. 
Although the overall number of thymocytes and splenic T 
cells  was  reduced  ,'-,10-fold in  the  IL-7Rc~-mutant mice 
(17),  essentially all  the  CD4 +  or CD8 +  mature  T  cells in 
these  organs  expressed  or13 TCR  (He,  Y.-W.,  and  T.R. 
Malek, unpublished observation). Furthermore, correspond- 
ingly higher than normal percentages of CD4-CD8-  thy- 
mocytes and splenic T  cells also expressed a13 TCR. These 
data indicate  that IL-7Rot signaling is not essential  for the 
rearrangement of the c~13 TCR. This conclusion is in con- 
trast to the observation that IL-7 induced V(D)J rearrange- 
ment of the  TCR  13 gene and sustained the  expression  of 
RAG-1  and  RAG-2 genes in vitro in  thymocyte suspen- 
sions  from mouse  embryos  (32).  When  mice  are  treated 
with  mAbs  to  IL-7,  the  earliest  T  cell  precursors,  i.e., 
CD44+CD25-CD4-CD8 -  thymocytes, inefficiendy make 
the  transition  to  the  next  stage  of thymocyte maturation, 
i.e., CD44+CD25+CD4-CD8 -  thymocytes (14). It is only 
after this time that TCR  13 gene rearrangement occurs (33). 
Thus,  we  favor a  predominant  role  for IL-7Ra signaling 
for the expansion and/or survival of the earliest T  cell pre- 
cursors in the  thymus without  an essential  role in  the  in- 
duction ofo~13 TCR  rearrangement. 
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